Close
Close
Treatment Database
Epoprostenol
Trade Name Flolan
Orphan Indication Primary pulmonary hypertension
USA Market Approval 20-09-1995
USA Designation Date 25-09-1985
Sponsor Glaxo Wellcome Inc.
5 Moore Drive
Research Triangle Park, North Carolina, 27709
More about Pulmonary Arterial Hypertension
Free Newsletter
Related Videos